Medical oncologist and lung cancer expert Roy S. Herbst discusses early data on drugs that target a mutated form of the KRAS protein.

by Anna Azvolinsky

Melvin Mann benefited from joining a pivotal clinical trial for chronic myelogenous leukemia, but participation came with logistical challenges.

by Melvin Mann

Many people know thyroid cancer as a cancer type with a relatively good prognosis, but the disease still has profound effects on patients and survivors, writes thyroid cancer survivor Carly Flumer.

by Carly Flumer

Letting children know they might have a mutation that increases their risk for cancer can be a challenge for patients. Experts stress there is no right or wrong way to share the information.

by Marci A. Landsmann

Patients find each other online and get support they say is unparalleled, but with openness comes concern about privacy.

by Kate Yandell

Forward Look

High cost may still limit access.

by Nancy Averett

Genetic testing for mutations in the BRCA1 and BRCA2 genes creates opportunities for cancer risk reduction. But 25 years after the mutations were discovered, some who could benefit from testing are still left out.

by Sue Rochman

Forward Look

New law mandates that cancer drugs get tested in kids in clinical trials.

by Sharon Tregaskis

From the Editor-in-Chief

Increased vaccination rates can help reduce cervical cancer as a worldwide health threat.

by William G. Nelson, MD, PhD

Forward Look

Programs aim to increase awareness of benefits.

by Sue Rochman